Scholars Central

Conference abstractPublished 16 Jul 2018

Personalized pharmacogenomics

Authors: Petr Starostik

University of Florida, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

GatorSeq Pharm is a pharmacogenomic gene assay we developed that predicts how patients will respond to a specific drug. The test determines the genotype/allelotype of each patient and correlates the results with the expected drug response based on published data and Clinical Pharmacogenetics Implementation Consortium recommendations. Personalized drug therapy can then be based on the individualâÂ?Â?s genetic makeup which accounts for differences in drug absorption, metabolism, and efficiency. Such genetic differences may explain why one drug works well for one person, but the same drug causes severe adverse effects in other individuals. The test was validated in a clinical CLIA-approved laboratory to genotype 11 most significant pharmacogenomic genes. The test results provides the ordering physician with actionable relevant data and recommendations to individualize patient care allowing them to make insightful treatment decisions.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Diagnostic Pathology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDiagnostic Pathology: Open Access
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Petr Starostik”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels